AB
About
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing several novel gene therapies to treat Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS), and other CNS diseases.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Cambridge, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Apic
Search Investors